|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Lung and Thoracic cancer
A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer
Eo Jin Kim, Yong-Hee Cho, Dong Ha Kim, Dae-Hyun Ko, Eun-Ju Do, Sang-Yeob Kim, Yong Man Kim, Jae Seob Jung, Yoonmi Kang, Wonjun Ji, Myeong Geun Choi, Jae Cheol Lee, Jin Kyung Rho, Chang-Min Choi
Cancer Res Treat.
2022;54(4):1005-1016. Published online December 3, 2021 DOI:
https://doi.org/10.4143/crt.2021.986
Web of Science 6
Crossref 5
Integrin αvβ3 Induces HSP90 Inhibitor Resistance via FAK Activation in
KRAS
-Mutant Non-Small Cell Lung Cancer
Shinkyo Yoon, Hannah Yang, Hyun-Min Ryu, Eunjin Lee, Yujin Jo, Seyoung Seo, Deokhoon Kim, Chang Hoon Lee, Wanlim Kim, Kyung Hae Jung, Sook Ryun Park, Eun Kyung Choi, Sang-We Kim, Kang-Seo Park, Dae Ho Lee
Cancer Res Treat.
2022;54(3):767-781. Published online September 30, 2021 DOI:
https://doi.org/10.4143/crt.2021.651
Web of Science 1
Crossref 1
Gastrointestinal cancer
Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer
Hye-Rim Seo, Ah-Rong Nam, Ju-Hee Bang, Kyoung-Seok Oh, Jae-Min Kim, Jeesun Yoon, Tae-Yong Kim, Do-Youn Oh
Cancer Res Treat.
2022;54(2):541-553. Published online August 6, 2021 DOI:
https://doi.org/10.4143/crt.2021.473
Web of Science 4
Crossref 4
General
Pan-cancer Analysis of Tumor Mutational Burden and Homologous Re
combination
DNA Damage Repair Using Targeted Next-Generation Sequencing
Hai-Yun Wang, Ling Deng, Ying-Qing Li, Xiao Zhang, Ya-Kang Long, Xu Zhang, Yan-Fen Feng, Yuan He, Tao Tang, Xin-Hua Yang, Fang Wang
Cancer Res Treat.
2021;53(4):973-982. Published online February 18, 2021 DOI:
https://doi.org/10.4143/crt.2020.798
Web of Science 6
Crossref 6
Clinical Impact of Somatic Variants in Homologous Re
combination
Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
Min Chul Choi, Sohyun Hwang, Sewha Kim, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Tae-Heon Kim, Haeyoun Kang, Hee Jung An
Cancer Res Treat.
2020;52(2):634-644. Published online January 6, 2020 DOI:
https://doi.org/10.4143/crt.2019.207
Web of Science 13
Crossref 13
Preclinical Efficacy of [V
4
Q
5
]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer
Juan Garona, Natasha T. Sobol, Marina Pifano, Valeria I. Segatori, Daniel E. Gomez, Giselle V. Ripoll, Daniel F. Alonso
Cancer Res Treat.
2019;51(2):438-450. Published online June 1, 2018 DOI:
https://doi.org/10.4143/crt.2018.040
Web of Science 17
Crossref 11
Irinotecan Monotherapy Versus Irinotecan-Based
Combination
as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
Yo-Han Cho, So Young Yoon, Soo-Nyung Kim
Cancer Res Treat.
2017;49(1):255-262. Published online May 18, 2016 DOI:
https://doi.org/10.4143/crt.2015.452
Web of Science 2
Crossref 3
Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges
Melissa M. Phillips, Michael T. Sheaff, Peter W. Szlosarek
Cancer Res Treat.
2013;45(4):251-262. Published online December 31, 2013 DOI:
https://doi.org/10.4143/crt.2013.45.4.251
Crossref 151
Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil
Combination
Chemotherapy Comparing with Cisplatin and 5-Fluorouracil
Combination
Chemotherapy in Patients with Advanced Gastric Cancer
Kyung Hee Lee, Myung Soo Hyun, Hoon-Kyo Kim, Hyung Min Jin, Jinmo Yang, Hong Suk Song, Young Rok Do, Hun Mo Ryoo, Joo Seop Chung, Dae Young Zang, Ho-Yeong Lim, Jong Youl Jin, Chang Yeol Yim, Hee Sook Park, Jun Suk Kim, Chang Hak Sohn, Soon Nam Lee
Cancer Res Treat.
2009;41(1):12-18. Published online March 31, 2009 DOI:
https://doi.org/10.4143/crt.2009.41.1.12
Crossref 23
The Efficacy of an Induction Chemotherapy
Combination
with Docetaxel, Cisplatin, and 5-FU Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Cancer
Jae-Sook Ahn, Sang-Hee Cho, Ok-Ki Kim, Joon-Kyoo Lee, Deok-Hwan Yang, Yeo-Kyeoung Kim, Je-Jung Lee, Sang-Chul Lim, Hyeoung-Joon Kim, Woong-Ki Chung, Ik-Joo Chung
Cancer Res Treat.
2007;39(3):93-98. Published online September 30, 2007 DOI:
https://doi.org/10.4143/crt.2007.39.3.93
Crossref 17
Gemcitabine Single or
Combination
Chemotherapy in Post Anthracycline and Taxane Salvage Treatment of Metastatic Breast Cancer: Retrospective Analysis of 124 Patients
Min Kyoung Kim, Sung-Bae Kim, Jin Hee Ahn, Soon Im Lee, Sei-Hyun Ahn, Byung Ho Son, Gyungyub Gong, Hak-Hee Kim, Jung-Shin Lee, Yoon-Koo Kang, Woo Kun Kim
Cancer Res Treat.
2006;38(4):206-213. Published online December 31, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.4.206
Crossref 1
Combination
Chemotherapy of Heptaplatin, Paclitaxel and 5-Fluorouracil in Patients with Advanced Gastric Cancer: a Pilot Study
Myung-Ju Ahn, Ho-Suck Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Oh Young Lee, Ho-Soon Choi, Sung-Joon Kwon
Cancer Res Treat.
2004;36(3):182-186. Published online June 30, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.3.182
Crossref 2
Effect of
Combination
Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
Hee Jung Kang, Min Kyoung Kim, Young Gil Kim, Jae Lyun Lee, Kyung Hee Lee, Myung Soo Hyun, Sung Hwa Bae, Hun Mo Ryoo
Cancer Res Treat.
2003;35(4):299-303. Published online August 31, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.4.299
Infusional 5-Fluorouracil, Leucovorin and Docetaxel in Advanced Gastric Cancer
Yong Tai Kim, Joo Hyuk Sohn, So Hun Kim, Sun Young Rha, Chul Kim, Jae Kyung Roh, Byung Soo Kim, Woo Ick Jang, Hyun Cheol Chung
Cancer Res Treat.
2003;35(2):123-129. Published online April 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.2.123
Crossref 1
Antitumor Activity of Oxaliplatin, 5-FU and Paclitaxel Given Alone or in
Combination
with ZD1839 in Human Gastric Carcinoma Cells in vitro
Ji Hyun Jang, Sang Hak Lee, Jin Hyoung Kang, Hee Sik Sun, Kazuto Nishio, Nagahiro Saijo, Hyo Jeong Kuh
Cancer Res Treat.
2002;34(5):372-381. Published online October 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.5.372
Crossref 2
Effect of Vinorelbine, Ifosfamide and Cisplatin
Combination
Chemotherapy in Stage III-IV Non-Small-Cell Lung Cancer
Young Chul Kim, So Young Lee, Hong Joo Cho, Jung A Kim, So Hyang Song, Chi Hong Kim, Hoon Kyo Kim, Meyung Im Ahn, Jin Young You, Sung Whan Kim, Deng Gon Cho, Kyu Do Cho, Jin Hyung Kang
Cancer Res Treat.
2002;34(5):352-356. Published online October 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.5.352
Phase II Study of Topotecan and Etoposide as Second-line Treatment in Chemotherapy-refractory Small-cell Lung Cancer
Chul Kim, Joo Hyuk Sohn, Joo Hang Kim, Se Kyu Kim, Young Sam Kim, Joon Chang, Jae Yong Cho
Cancer Res Treat.
2002;34(5):334-338. Published online October 31, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.5.334
A Phase II Study of Oxaliplatin Combined with 5-Fluorouracil and Leucovorin (Mayo Clinic Regimen) in 5-Fluorouracil Refractory Colorectal Cancer
Yee Zee Bae, Jae Hyuk Jung, Chang Hoon Moon, Seong Hyun Kim, Hyuk Chan Kwon, Jae Seok Kim, Hyo Jin Kim
Cancer Res Treat.
2002;34(3):218-222. Published online June 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.3.218
Crossref 4
MINE (mesna, ifosfamide, mitoxantrone, etoposide) Chemotherapy as a Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Seong Hoon Chang, Yang Soo Kim, Wan Kyu Eo
Cancer Res Treat.
2002;34(2):145-152. Published online April 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.2.145
Crossref 1
Phase II Trial of Gemcitabine, UFT-E, Leucovorin
Combination
Chemotherapy in Advanced Pancreatic Adenocarcinoma
So Young Yoon, Kyong Hwa Park, Sang Chul Oh, Jae Hong Seo, Chul Won Choi, Byung Soo Kim, Jae Seon Kim, Chang Duck Kim, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim
Cancer Res Treat.
2002;34(2):111-116. Published online April 30, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.2.111
Crossref 1
Efficacy of
Combination
Chemotherapy with Paclitaxel and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer
Eun Jung Rhee, Hyun Sik Jeong, Seung Sei Lee
Cancer Res Treat.
2002;34(1):28-33. Published online February 28, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.1.28
Crossref 3
A Phase II Study with Gemcitabine and Carboplatin in Patients with Advanced Non-small Cell Lung Cancer
Jae Wan Park, Hwan Yang Park, Yong Bae Park, Jung Won Kang, Sung Hung Kim, Gwi Lae Lee, Bong Seog Kim, Yong Ho Roh
Cancer Res Treat.
2002;34(1):23-27. Published online February 28, 2002 DOI:
https://doi.org/10.4143/crt.2002.34.1.23
Crossref 2
Combination
Chemotherapy of Oxaliplatin, 5-Fluorouracil, and Leucovorin in 5-Fluorouracil-Pretreated Patients with Metastatic Colorectal Cancer
Soo Mee Bang, Eun Kyung Cho, Jae Hwan Oh, Heung Moon Chang, Jin Seok Ahn, Jung Ae Lee, Young Iee Park, Myung Jue Ahn, Young Suk Park, Dong Bok Shin, Jae Hoon Lee
Cancer Res Treat.
2001;33(5):414-419. Published online October 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.5.414
Crossref 1
Combination
Chemotherapy with Mitomycin C, Vinorelbine, and Cisplatin (MVrP) in Patients with Advanced Non-Small Cell Lung Cancer
Hun Gu Kim, Gyeong Won Lee, Dae Hwan Lee, In Gyu Hwang, Ki Shik Shim, Won Sup Lee, Jong Deog Lee, Joung Soon Jang, Young Sil Hwang, Jong Seok Lee
Cancer Res Treat.
2001;33(5):377-384. Published online October 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.5.377
Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer
Yo Han Joh, Tae You Kim, Im Il Na, Do Youn Oh, Byung Su Kim, Jee Hyun Kim, Do Yeun Kim, Se Hoon Lee, Chul Gyu Yoo, Choon Taek Lee, Young Whan Kim, Dae Seog Heo, Yung Jue Bang, Sung Koo Han, Young Soo Shim, Noe Kyeong Kim
Cancer Res Treat.
2001;33(5):373-376. Published online October 31, 2001 DOI:
https://doi.org/10.4143/crt.2001.33.5.373
Crossref 1
Results of Treatment with ProMACE - CytaBOM Regimen for Aggressive Non - Hodgkins Lymphoma
Wan Kyu Eo
J Korean Cancer Assoc.
2000;32(1):168-177.
Combination
Chemotherapy with VP - 16 , Ifosfamide , and Cisplatin ( VIP ) in the Advanced Non - Small Cell Lung Cancer
Yong Seon Cho, Si Young Kim, Jeong Hee Kim, Hwi Joong Yoon, Kyung Sam Cho
J Korean Cancer Assoc.
2000;32(1):86-92.
The Effect of
Combination
Chemotherapy with Vinorelbine, Carboplatin, and Ifosfamide in Patients with Advanced Non-Small Cell Lung Cancer
Young Woo Lee, Baek Yeol Ryoo, Tae You Kim, Bong Seog Kim, Yeon Hee Park, Hyun Ju Hong, Jin Young Kwag, Sang Won Lee, Yoon Koo Kang
J Korean Cancer Assoc.
1999;31(6):1227-1235.
5-Fluorouracil, Leucovorin ( FL )
Combination
Chemotherapy in Advanced or Recurrent Colo - rectal Cancer
Jeong Hwan Cho, Hyuk Chan Kwon, Hyo Jin Kim
J Korean Cancer Assoc.
1999;31(5):1003-1010.
Phase 2 Trial of FLP ( 5-FU , Leucovorin , Cisplatin )
Combination
Chemotherapy for Advanced Gastric Cancer
Young Iee Park, Moon Hee Lee, Sung Woo Han, Woo Jung Park, Dong Gyu Kim, Jin Lee, Jin Seok Ahn, Jung Ae Rhee, In Sook Woo, Young Suk Park
J Korean Cancer Assoc.
1998;30(1):55-62.
1
2
Journal Impact Factor 4.6